ArticleClinical cancer research : an official journal of the American Association for Cancer Research2008

PTEN loss does not predict for response to RAD001 (Everolimus) in a glioblastoma orthotopic xenograft test panel.

Lin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.